Drug Profile
NCX 900
Latest Information Update: 31 Jul 2012
Price :
$50
*
At a glance
- Originator NicOx
- Class
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pulmonary hypertension
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Pulmonary hypertension (unspecified route)
- 06 Nov 1998 Preclinical development for Pulmonary hypertension (Unknown route)